Trial Condition(s):

Vaginal Candida

Study on the safety of the approved product Empedic L Cream during its routine use (active ingredient is Clotrimazole 1%)

Bayer Identifier:

19439

ClinicalTrials.gov Identifier:

NCT03599323

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Researchers already did trials that showed Empecid L Cream worked for patients with Vaginal yeast infection who were in those trials. In this trial, they want to learn if consumers that use the cream under the guidance of a pharmacist have any medical problems during the trial

Inclusion Criteria
- Consumers who self-select and are then deemed appropriate users of the product by the pharmacist for treatment of Vulvar itching with rash due to recurrent vaginal candida (only in patients previously diagnosed and treated by a doctor).
Exclusion Criteria
- Patient with first episode 
- Patient with allergy to Empecid Cream (Clotrimazole)
- Patient under 15 years old/ beyond 60 years old
- Pregnant women or women who may possibly be pregnant
- Patient with diabetes 
- Patient who repeats indicated symptom frequently,  have recurrent episodes (once every month or two, or twice or more within 6 months).
- Patients who does not know whether it is a recurrence symptom
- Patients who have a fever, chills, lower abdominal pain, back or shoulder pain, colored or bloody vaginal discharge, fishy-smelling vaginal discharge, cessation of menses, irregular or abnormal bleeding from the vagina, or ulcer, edema or erosion in the vagina or vulva suggesting they may have a different disease.

Trial Summary

Enrollment Goal
1033
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Mycelex-7 (Clotrimazole, BAYB5097)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many Locations

Many Locations, Japan

Status
Completed
 

Trial Design